Clinical Trials - December 1, 2014
More Success for AZ Drug
Amgen and AstraZeneca have racked up their third straight Phase III win for brodalumab in plaque psoriasis, beating J&J’s Stelara in a head-to-head study. The news comes just two weeks after the pharmacy partners posted their latest positive results, positioning them for a run at regulators on both sides of the Atlantic. There are two key […]